LIA vs. LIA + ACB-iPACK Block for Total Knee Arthroplasty
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorWomen's College Hospital
About this trial
LIA is the mainstay of postoperative analgesia in patients having knee arthroplasty. The combination of ACB-iPACK blocks has also been proposed as an effective analgesic modality for total knee arthroplasty. However, whether combining these two modalities yields any important incremental analgesic benefit remains unclear. The investigators hypothesized that the addition of ACB and iPACK blocks to LIA will yield clinically important analgesic benefits compared to LIA alone in patients having total knee arthroplasty.
Eligibility criteria
Qualifiers
ASA classification I-III
BMI < 35 kg/m2
Having elective unilateral total knee arthroplasty
Disqualifiers
Bilateral knee surgery.
Pre-existing neurological deficit or peripheral neuropathy in the lower the lower limbs
Severe, poorly controlled cardiac conditions, significant arrhythmias, severe valvular heart diseases
Severe, poorly controlled respiratory conditions (severe COPD, severe interstitial lung disease, severe / poorly controlled asthma)
Trial design
Treatments tested in this trial
- Local infiltration analgesia
- Ultrasound-guided adductor canal block
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov